How can you benefit from new market opportunities in OTC after the shock of covid-19?

COVID-19, OTC

All of our countries implemented sanitary measures for stopping the global Covid-19 pandemic:...

Our brand new 2020 Syndicated Surveys

COVID-19, Syndicated Studies

Our range of syndicated studies now covers over 30 indications, many of them with results already...

COVID-19 2nd Phase - Impact on Physicians’ Practice - Syndicated Study

COVID-19, Syndicated Studies

How does COVID-19 affectthe HCPS relationships with patients and with the pharmaceutical industry?...

COVID-19 road to recovery: 5 key insights from our syndicated study

COVID-19, Syndicated Studies

As the global number of infected cases surpasses 46 million (Nov 2, 2020), there is a non-stop...

COVID-19 INFO #4 Data Collection in 35+ Countries

COVID-19

This series of INFO posts is designed to keep you updated with the key developments in our industry...

French GPs React to COVID-19: AplusA Poll Wave 4

COVID-19

The latest results from our ongoing poll among French GPs monitoring their experiences and...

French GPs React to COVID-19: Results from AplusA Poll Wave 3

COVID-19

The latest results from our ongoing poll among French GPs monitoring their experiences and...

COVID-19 INFO #3: Data Collection and More

COVID-19

As the COVID-19 situation develops and as AplusA teams have been receiving questions regarding the...

COVID-19 INFO #2: HCP Respondent Response

COVID-19

As the COVID-19 situation develops we want to keep our clients and community updated on the impact...

Coronavirus: The Evolution of its Many Names

COVID-19

AplusA utilized social media analysis tools to observe the evolution of the use of the different...